CV Disease in Special Populations

Erkihun Amsalu, Tan Van Nguyen, Harry Klimis, et al

Read time: 19m 13s

Broadcast

CV Disease in Special Populations

Heart Failure
Recovery of Anthracycline-Induced Cardiomyopathy

Joe Carver, Osnat Itzhaki Ben Zadok, Jose Alvarez-Cardona

Watch time: 54m 49s

Broadcast

CV Disease in Special Populations

Demographic
Phenotypes of Myocardial Dysfunction on Serial Echocardiography and CMR in…

Dan Lenihan, Flora Huang, Jose Alvarez-Cardona

Watch time: 1h 53s

Giulia Tamburrini, Celia de Cobos García, Teresa López Fernández

Read time: 23m 13s

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)
ICOS-CORE Whitepaper Calls for Rigorous Evidence to Support Cardio-oncology Rehabilitation

Radcliffe Cardiology

AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s

Broadcast

CV Disease in Special Populations
NHC 2025 - Focus on Cardiomyopathy

Perry Elliott, Rodney Falk, Marianna Fontana

Broadcast

CV Disease in Special Populations
NHC 2025 - Focus on Amyloidosis

Perry Elliott, Rodney Falk, Marianna Fontana

ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Harriette Van Spall, James L Januzzi

Watch time: 23m 6s

Broadcast

CV Disease in Special Populations
New Horizons in Amyloidosis (NHA) 2024

Marianna Fontana, Julian Gillmore, Laura Obici , et al

ACC 23: Statins to Protect Heart During Cancer Treatment: The STOP-CA Trial

Marielle Scherrer-Crosbie

Watch time: 5m 59s

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)

Jelena Celutkiene, Arunas Vaitkevicius, Silvija Jakstiene, et al

Erkihun Amsalu, Tan Van Nguyen, Harry Klimis, et al

Read time: 19m 13s

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Giulia Tamburrini, Celia de Cobos García, Teresa López Fernández

Read time: 23m 13s

Broadcast

CV Disease in Special Populations

Heart Failure
Recovery of Anthracycline-Induced Cardiomyopathy

Joe Carver, Osnat Itzhaki Ben Zadok, Jose Alvarez-Cardona

Watch time: 54m 49s

Wan Xian Chan, Weiqin Lin, Raymond Ching Chiew Wong

Carine E Hamo, Michelle W Bloom

Martin Nicol, Mathilde Baudet, Alain Cohen-Solal

Broadcast

CV Disease in Special Populations

Demographic
Phenotypes of Myocardial Dysfunction on Serial Echocardiography and CMR in…

Dan Lenihan, Flora Huang, Jose Alvarez-Cardona

Watch time: 1h 53s

Alessandra Cuomo, Alessio Rodolico, Amalia Galdieri, et al

Media

Broadcast

CV Disease in Special Populations
New Horizons in Amyloidosis (NHA) 2024

Marianna Fontana, Julian Gillmore, Laura Obici , et al

ACC 23: Statins to Protect Heart During Cancer Treatment: The STOP-CA Trial

Marielle Scherrer-Crosbie

Watch time: 5m 59s

Broadcast

Anticoagulation

Vascular Disease and Surgery
Radcliffe Premiere TV: ESC 2022

Watch time: 3h 52m 31s
GALACTIC-HF Subgroup Analysis: Omecamtiv Mecarbil Effective Across Ethnic Groups

David Lanfear

Watch time: 5m 27s
Introduction to CV Health Concerns Among LGBTQ+ Populations

Billy A Caceres, Carl Streed

Watch time: 29m 19s
View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem

Watch time: 36m 1s
Cardio-oncology Discussion: Primary PCI in Cancer Patients

Arjun K Ghosh, Deepak L Bhatt, Cezar Iliescu, et al

Watch time: 36m 6s
Masterclass on The Global Burden of CV Disease in Women

Birgit Vogel, Harriette Van Spall

Watch time: 20m 32s
ESC 2021 Discussion: The FIGARO-DKD Trial

Bertram Pitt, Harriette Van Spall

Watch time: 15m 2s
View from the Thoraxcenter – What's Hot at ESC 2021

Joost Daemen, Nicolas M Van Mieghem

Watch time: 25m 18s
ACC 21 Edition of Masterclass: Hostility & Harassment: How to Change Workplace Culture in Cardiology

Harriette Van Spall, Garima Sharma, Laxmi Mehta, et al

Watch time: 17m 58s
Masterclass: Smashing the Glass Ceiling

Cindy Grines, Harriette Van Spall

Watch time: 15m 10s

Media

Broadcast

CV Disease in Special Populations

Heart Failure
Recovery of Anthracycline-Induced Cardiomyopathy

Joe Carver, Osnat Itzhaki Ben Zadok, Jose Alvarez-Cardona

Watch time: 54m 49s

Broadcast

CV Disease in Special Populations

Demographic
Phenotypes of Myocardial Dysfunction on Serial Echocardiography and CMR in…

Dan Lenihan, Flora Huang, Jose Alvarez-Cardona

Watch time: 1h 53s

Broadcast

CV Disease in Special Populations
NHC 2025 - Focus on Cardiomyopathy

Perry Elliott, Rodney Falk, Marianna Fontana

Broadcast

CV Disease in Special Populations
NHC 2025 - Focus on Amyloidosis

Perry Elliott, Rodney Falk, Marianna Fontana

Broadcast

CV Disease in Special Populations
New Horizons in Amyloidosis (NHA) 2024

Marianna Fontana, Julian Gillmore, Laura Obici , et al

Broadcast

Imaging & Diagnostics

Prevention & Chronic Conditions
5-FU Cardiotoxicity: Mechanisms and Management Strategies

Arjun K Ghosh, Mark Westwood,

Watch time: 39m 25s

Broadcast

Heart Failure
Cardiac Toxicity of Cancer Chemotherapy

Aarti Asnani,

Watch time: 54m

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)
Masterclass: Smashing the Glass Ceiling

Cindy Grines, Harriette Van Spall

Watch time: 15m 10s
View from the Thoraxcenter – What's Hot at ESC 2021

Joost Daemen, Nicolas M Van Mieghem

Watch time: 25m 18s
Cardio-oncology Discussion: Primary PCI in Cancer Patients

Arjun K Ghosh, Deepak L Bhatt, Cezar Iliescu, et al

Watch time: 36m 6s

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Articles

Bidirectional Relationship Between Cancer and Heart Failure

Edoardo Bertero

,

Pietro Ameri

,

Christoph Maack

,

Published:

24 May 2019

Citation:

Cardiac Failure Review 2019;5(2):106–11.

DOI:

https://doi.org/10.15420/cfr.2019.1.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 28
  • Citations: 41

Subclinical Left Ventricular Dysfunction During Chemotherapy

Martin Nicol

,

Mathilde Baudet

,

Alain Cohen-Solal

,

Published:

11 February 2019

Citation:

Cardiac Failure Review 2019;5(1):31–6.

DOI:

https://doi.org/10.15420/cfr.2018.25.1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 35
  • Citations: 28

The New Heart Failure Association Definition of Advanced Heart Failure

Marco Metra

,

Elisabetta Dinatolo

,

Nicolò Dasseni

,

Published:

11 February 2019

Citation:

Cardiac Failure Review 2019;5(1):5–8.

DOI:

https://doi.org/10.15420/cfr.2018.43.1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 55
  • Citations: 30

The Future Role of Cardio-oncologists

Radek Pudil

,

Citation:

Cardiac Failure Review 2017;3(2):140–2.

DOI:

https://doi.org/10.15420/cfr.2017:16:1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 8
  • Citations: 13